Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 793 across all filing types
Latest filing 2021-01-08 Earnings Release
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated January 8, 2021, announcing the unaudited financial results for the third quarter and nine months ended December 31, 2020. It includes key financial highlights such as total income, EBITDA, net profit, and operational metrics. The document is explicitly labeled as a 'Press Release' and contains summary financial data and management commentary but does not include full financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). The length is 6236 characters, which is sufficient for a press release but not a full report. The document is not an announcement of a report publication but the actual press release of financial results. Therefore, the appropriate classification is Earnings Release (ER). Q3 2021
2021-01-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an invitation to a conference call discussing the Q3FY21 results of Shalby Limited. It includes details such as date, time, dial-in numbers, and contact information for RSVP. There is no actual financial data or analysis presented, only an announcement of the event. This fits the definition of a Call Transcript (CT) document type, but since it is only an invitation and not the transcript itself, it is more accurately classified as a Regulatory Filing (RNS) as a general regulatory announcement. The document length is short (1816 characters), and it does not contain the transcript or detailed financial discussion, only the call invitation.
2021-01-08 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation for the quarter and nine months ended December 31, 2020" and is submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements). It contains detailed financial and operational performance data for Q3 FY2021, including income, EBITDA, net profit, occupancy rates, and other key metrics. The content is structured as a presentation with charts, tables, and management commentary. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The presence of detailed quarterly financial data and operational metrics confirms it is a quarterly investor presentation rather than a simple earnings release or regulatory filing. Therefore, the document fits the category of an Investor Presentation (IP).
2021-01-08 English
Financial Result Updates
Regulatory Filings
2021-01-08 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of the outcome of a Board Meeting where the company approved and disclosed its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2020. It includes financial tables, notes to the financial results, and an independent auditor's review report pursuant to SEBI regulations. The document is about quarterly financial results with substantive financial data and analysis, not just a brief earnings highlight or a report publication announcement. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-01-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2020. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialized/rematerialized securities details furnished to stock exchanges. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a formal attestation related to regulatory requirements. Given the nature and length (4062 characters), it is not a full report but a regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-01-07 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.